Search


Current filters:




Clear current filters  or Add more filters

View Option



Results 1-10 of 10 (Search time: 0.004 seconds).
  • previous
  • 1
  • next

  Prognostic utility of beta-tubulin isotype III and correlations with other molecular and clinicopathological variables in patients with early breast cancer: a translational Hellenic Cooperative Oncology Group (HeCOG) study (Journal article)

  Prognostic significance of VEGF immunohistochemical expression and tumor angiogenesis in head and neck squamous cell carcinoma (Journal article)

  Triple-negative phenotype is of adverse prognostic value in patients treated with dose-dense sequential adjuvant chemotherapy: a translational research analysis in the context of a Hellenic Cooperative Oncology Group (HeCOG) randomized phase III trial (Journal article)

  Comparison of the dysadherin and E-cadherin expression in primary lung cancer and metastatic sites (Journal article)

  Hypoxia-induced tumor angiogenic pathway in head and neck cancer: an in vivo study (Journal article)

  Correlation of mammographic appearance and molecular prognostic factors in high-grade breast carcinomas (Journal article)

  Estrogen receptor beta (ERbeta) expression in breast carcinomas is not correlated with estrogen receptor alpha (ERalpha) and prognosis: the Greek experience (Journal article)

  Evidence for lymphangiogenesis and its prognostic implications in head and neck squamous cell carcinoma (Journal article)

  Estrogen receptor beta (ERbeta) protein expression correlates with BAG-1 and prognosis in brain glial tumours (Journal article)

  Dysadherin expression in head and neck squamous cell carcinoma: association with lymphangiogenesis and prognostic significance (Journal article)